Moors & Cabot’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $290K | Buy |
745
+49
| +7% | +$19.1K | 0.01% | 661 |
|
|
2025
Q1 | $303K | Sell |
696
-535
| -43% | -$233K | 0.02% | 638 |
|
|
2024
Q4 | $454K | Sell |
1,231
-767
| -38% | -$283K | 0.02% | 522 |
|
|
2024
Q3 | $1.04M | Sell |
1,998
-9
| -0.4% | -$4.68K | 0.05% | 324 |
|
|
2024
Q2 | $1.09M | Sell |
2,007
-180
| -8% | -$97.5K | 0.06% | 286 |
|
|
2024
Q1 | $1.13M | Buy |
2,187
+61
| +3% | +$31.6K | 0.06% | 282 |
|
|
2023
Q4 | $1M | Buy |
2,126
+89
| +4% | +$42K | 0.06% | 282 |
|
|
2023
Q3 | $887K | Buy |
2,037
+468
| +30% | +$204K | 0.06% | 282 |
|
|
2023
Q2 | $697K | Buy |
1,569
+271
| +21% | +$120K | 0.05% | 350 |
|
|
2023
Q1 | $597K | Buy |
1,298
+227
| +21% | +$104K | 0.04% | 378 |
|
|
2022
Q4 | $549K | Buy |
1,071
+527
| +97% | +$270K | 0.04% | 398 |
|
|
2022
Q3 | $247K | Buy |
+544
| New | +$247K | 0.02% | 632 |
|
|
2022
Q2 | – | Sell |
-510
| Closed | -$251K | – | 819 |
|
|
2022
Q1 | $251K | Buy |
+510
| New | +$251K | 0.02% | 695 |
|